Yungen Xu

机构：China Pharmaceutical University, Guangdong Pharmaceutical University, State Key Laboratory of Natural Medicine · ORCID：0000-0001-6586-8482

发表论文 190 篇 · 总被引 3794 次 · h-index 36

代表论文

• Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression (2024 · Journal of Medicinal Chemistry · 被引 27)
• Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy (2023 · Journal of Medicinal Chemistry · 被引 20)
• Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy (2024 · Journal of Medicinal Chemistry · 被引 16)
• Discovery of the first ataxia telangiectasia and Rad3-related (ATR) degraders for cancer treatment (2024 · European Journal of Medicinal Chemistry · 被引 16)
• An overview of limonoid synthetic derivatives as promising bioactive molecules (2023 · European Journal of Medicinal Chemistry · 被引 15)
• Discovery and Optimization of Novel Apo-IDO1 Inhibitors by a Pharmacophore-Based Structural Simplification Strategy (2025 · Journal of Medicinal Chemistry · 被引 12)